Value of metagenomic next-generation sequencing in children with hemophagocytic syndrome with central nervous system involvement
ZHANG Hai-Yang, TANG Mao-Ting, QING Lu, LI De-Yuan, QIAO Li-Na
Department of Pediatric Intensive Care Unit, West China Second University Hospital, Sichuan University/Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu 610041, China
Abstract Objective To study the value of metagenomic next-generation sequencing (mNGS) in detecting intracranial Epstein-Barr virus (EBV) infection in children with hemophagocytic syndrome (HPS) with central nervous system involvement. Methods A retrospective analysis was performed for the cerebrospinal fluid mNGS results of 30 HPS children with central nervous system involvement, which were compared with the results of cerebrospinal fluid EBV-DNA detection and serum EBV antibody profile. The change in serum EBV-DNA copy number after treatment was used to evaluate the efficacy of targeted therapy. Results The positive rate of EBV in cerebrospinal fluid determined by mNGS was significantly higher than that of EBV-DNA in cerebrospinal fluid (100% vs 10%, P<0.001) and had no significant difference from the positive rate of serum EBV antibody profile (100% vs 93%, P>0.05). The median number of sequences determined by mNGS was 2 400, and serum EBV-DNA copy number before treatment was moderately positively correlated with the number of EBV sequences (rs=0.693, P<0.001). The multiple linear regression analysis showed that the number of sequences determined by mNGS in cerebrospinal fluid increased with the increase in serum EBV-DNA copy number before treatment (P<0.05). Conclusions EBV-associated HPS often results in EBV-infected viral encephalitis, and mNGS can significantly increase the detection rate of EBV in cerebrospinal fluid, which may help with clinical diagnosis.
ZHANG Hai-Yang,TANG Mao-Ting,QING Lu et al. Value of metagenomic next-generation sequencing in children with hemophagocytic syndrome with central nervous system involvement[J]. CJCP, 2022, 24(11): 1226-1230.
ZHANG Hai-Yang,TANG Mao-Ting,QING Lu et al. Value of metagenomic next-generation sequencing in children with hemophagocytic syndrome with central nervous system involvement[J]. CJCP, 2022, 24(11): 1226-1230.
Henter JI, Horne A, Aricó M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis[J]. Pediatr Blood Cancer, 2007, 48(2): 124-131. PMID: 16937360. DOI: 10.1002/pbc.21039.
Vine LJ, Shepherd K, Hunter JG, et al. Characteristics of Epstein-Barr virus hepatitis among patients with jaundice or acute hepatitis[J]. Aliment Pharmacol Ther, 2012, 36(1): 16-21. PMID: 22554291. DOI: 10.1111/j.1365-2036.2012.05122.x.
Fryer JF, Heath AB, Wilkinson DE, et al. A collaborative study to establish the 1st WHO international standard for Epstein-Barr virus for nucleic acid amplification techniques[J]. Biologicals, 2016, 44(5): 423-433. PMID: 27461128. DOI: 10.1016/j.biologicals.2016.04.010.
Zhang B, Zhou J, Gui R, et al. Metagenomic next generation sequencing in the detection of pathogens in cerebrospinal fluid of patients after alternative donor transplantation: a feasibility analysis[J]. Front Cell Infect Microbiol, 2021, 11: 720132. PMID: 34595132. PMCID: PMC8476959. DOI: 10.3389/fcimb.2021.720132.
Wang S, Chen Y, Wang D, et al. The feasibility of metagenomic next-generation sequencing to identify pathogens causing tuberculous meningitis in cerebrospinal fluid[J]. Front Microbiol, 2019, 10: 1993. PMID: 31551954. PMCID: PMC6733977. DOI: 10.3389/fmicb.2019.01993.
Carbo EC, Blankenspoor I, Goeman JJ, et al. Viral metagenomic sequencing in the diagnosis of meningoencephalitis: a review of technical advances and diagnostic yield[J]. Expert Rev Mol Diagn, 2021, 21(11): 1139-1146. PMID: 34607520. DOI: 10.1080/14737159.2021.1985467.
18 Zykova TA, Shevyakova EA, Pustovaya IV, et al. Differences in serological profiles of Epstein-Barr virus infection in patients with head and neck tumors and lymphomas[J]. J Clin Oncol, 2022, 40(16_suppl): e18055. DOI: 10.1200/JCO.2022.40.16_suppl.e18055.
19 Williams S, Hassan-Smith G. 075?Meningitis management audit at a single centre: further support for culture-independent techniques in diagnosing meningitis[J]. J Neurol Neurosurg Psychiatry, 2019, 90(12): A26. DOI: 10.1136/jnnp-2019-ABN-2.87.
20 Piantadosi A, Mukerji S, Ye S, et al. 868. Prospective pathogen detection in patients with central nervous system inflammation using metagenomic sequencing[J]. Open Forum Infect Dis, 2018, 5(suppl_1): S23. DOI: 10.1093/ofid/ofy209.053.
